Cannell & Co’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.16M Buy
2,205
+45
+2% +$24K 0.04% 164
2023
Q3
$1.09M Buy
2,160
+380
+21% +$187K 0.04% 158
2023
Q2
$856K Hold
1,780
0.03% 177
2023
Q1
$841K Hold
1,780
0.03% 178
2022
Q4
$944K Buy
1,780
+477
+37% +$253K 0.03% 171
2022
Q3
$658K Sell
1,303
-225
-15% -$118K 0.03% 189
2022
Q2
$785K Sell
1,528
-25
-2% -$12.6K 0.03% 181
2022
Q1
$792K Sell
1,553
-910
-37% -$439K 0.02% 194
2021
Q4
$1.24M Buy
2,463
+700
+40% +$317K 0.04% 170
2021
Q3
$689K Sell
1,763
-2,605
-60% -$1.08M 0.02% 202
2021
Q2
$1.75M Sell
4,368
-455
-9% -$181K 0.05% 155
2021
Q1
$1.79M Buy
4,823
+1,160
+32% +$402K 0.06% 150
2020
Q4
$1.28M Sell
3,663
-700
-16% -$235K 0.04% 156
2020
Q3
$1.36M Sell
4,363
-189
-4% -$58.1K 0.05% 133
2020
Q2
$1.34M Buy
+4,552
New +$1.3M 0.05% 131

Other funds holding UNH

Cannell & Co's UNH Position: Q4 2023 in Review

Cannell & Co increased its UnitedHealth (UNH) stake by 2.1% in Q4 2023, buying an estimated $24K and bringing the position to 2,205 shares worth $1.16M. The position accounts for 0.04% of the portfolio, ranked #164.

Cannell & Co first reported a position in UNH in Q2 2020 and has held it in 15 quarters since. The position peaked at $1.79M in Q1 2021. 3,417 funds tracked by Wall St. Rank hold UNH as of Q4 2023.

  • Cannell & Co held 2,205 shares of UnitedHealth worth $1.16M as of Q4 2023.
  • Cannell & Co bought 45 UnitedHealth shares in Q4 2023, an estimated $24K.
  • UnitedHealth made up 0.04% of Cannell & Co's portfolio in Q4 2023, its #164 holding.
  • Cannell & Co first reported a position in UnitedHealth in Q2 2020 and has held it in 15 quarters since.
  • Cannell & Co's UnitedHealth position peaked at $1.79M in Q1 2021.
  • 3,417 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2023.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.